Clinical Trial Update: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of a novel malathion formulation for head lice in infants and toddlers; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice Infestation

Drugs mentioned

• Malathion (malathion)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Lice Infestations | Phase 2 | Status: TERMINATED